{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:49:03Z","timestamp":1761486543169},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1016\/s0304-3835(01)00737-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T13:36:39Z","timestamp":1027604199000},"page":"93-99","source":"Crossref","is-referenced-by-count":6,"title":["Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145\/AR)"],"prefix":"10.1016","volume":"176","author":[{"given":"Osamu","family":"Nagakawa","sequence":"first","affiliation":[]},{"given":"Jun","family":"Murata","sequence":"additional","affiliation":[]},{"given":"Akira","family":"Junicho","sequence":"additional","affiliation":[]},{"given":"Tadashi","family":"Matsuda","sequence":"additional","affiliation":[]},{"given":"Yasuyoshi","family":"Fujiuchi","sequence":"additional","affiliation":[]},{"given":"Hideki","family":"Fuse","sequence":"additional","affiliation":[]},{"given":"Ikuo","family":"Saiki","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0304-3835(01)00737-6_BIB1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/225863a0","article-title":"Potent peripheral and splanchnic vasodilator peptide from normal gut","volume":"225","author":"Said","year":"1970","journal-title":"Nature"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB3","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1073\/pnas.74.8.3424","article-title":"Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals","volume":"74","author":"Giachetti","year":"1977","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB4","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1210\/en.135.6.2662","article-title":"Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions","volume":"135","author":"Usdin","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0896-6273(92)90101-I","article-title":"Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide","volume":"8","author":"Ishihara","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0014-5793(93)81668-P","article-title":"The VIP2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide","volume":"334","author":"Lutz","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/bbrc.1993.1658","article-title":"Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor","volume":"193","author":"Sreedharan","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/bbrc.1995.1515","article-title":"Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor","volume":"209","author":"Adamou","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB9","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1073\/pnas.88.11.4986","article-title":"Cloning and expression of the human vasoactive intestinal peptide receptor","volume":"88","author":"Sreedharan","year":"1991","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0016-5085(80)90674-5","article-title":"Effect of VIP infusion on water and ion transport in the human jejunum","volume":"78","author":"Krejs","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(90)90079-L","article-title":"Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide","volume":"18","author":"Itoh","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB12","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.4049\/jimmunol.153.4.1762","article-title":"Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide","volume":"153","author":"Johnson","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/287343a0","article-title":"VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion","volume":"287","author":"Ahren","year":"1980","journal-title":"Nature"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.1992.tb03027.x","article-title":"Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells","volume":"87","author":"Ishioka","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jcp.1041500310","article-title":"Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line","volume":"150","author":"Gamet","year":"1992","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB16","first-page":"3486","article-title":"Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist","volume":"56","author":"Zia","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB17","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1073\/pnas.90.10.4345","article-title":"Vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth","volume":"90","author":"Moody","year":"1993","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB18","first-page":"1475","article-title":"Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells","volume":"57","author":"Jiang","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/343564a0","article-title":"Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts","volume":"343","author":"Pincus","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1464-410X.1991.tb15257.x","article-title":"The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine [beta]-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia","volume":"68","author":"Cohen","year":"1991","journal-title":"Br. J. Urol."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB21","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1073\/pnas.92.7.2939","article-title":"Structure, expression and chromosomal localization of the type1 human vasoactive intestinal peptide receptor gene","volume":"92","author":"Sreedharan","year":"1995","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/BF01119878","article-title":"Cyclic AMP response to vasoactive intestinal peptide and [beta]-adrenergic or cholinergic agonist in isolated epithelial cells of rat ventral prostate","volume":"5","author":"Carmera","year":"1985","journal-title":"Biosci. Rep."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0167-0115(96)00086-9","article-title":"Vasoactive intestinal peptide stimulates prostate-specific antigen secretion by LNCaP cells","volume":"65","author":"Gkonos","year":"1996","journal-title":"Regul. Pept."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB24","first-page":"1846","article-title":"In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging","volume":"36","author":"Reubi","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0167-0115(95)00072-J","article-title":"Neuroendocrine peptides stimulates adenyl cyclase in normal and malignant prostate cells","volume":"59","author":"Gkonos","year":"1995","journal-title":"Regul. Pept."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0022-5347(17)36349-8","article-title":"Differential effect of peptide hormones bombesin, vasoactive intestinal polypeptide, and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells","volume":"149","author":"Hoosein","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1442-2042.2001.00250.x","article-title":"Effect of prostatic neuropeptides on migration of prostate cancer cell lines","volume":"8","author":"Nagakawa","year":"2001","journal-title":"Int. J. Urol."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3835(98)00186-4","article-title":"Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells","volume":"133","author":"Nagakawa","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-0045(20000201)42:2<137::AID-PROS8>3.0.CO;2-U","article-title":"Type 1 vasoactive intestinal peptide receptor expression in PC3\/AR cells in evidence of prostate epithelial differentiation","volume":"42","author":"Gkonos","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB30","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1073\/pnas.95.5.2122","article-title":"CREB-binding protein in androgen receptor-mediated signaling","volume":"95","author":"Aaransialo","year":"1998","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-5793(00)01444-7","article-title":"SOCS-1 can suppress CD3\u03b6- and Syk-mediated NF-AT activation in a non-lymphoid cell line","volume":"472","author":"Matsuda","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1023\/A:1006567229929","article-title":"4-[3,5-Bis(trimethylsilyl)benzamindo] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor bearing animals","volume":"16","author":"Murakami","year":"1998","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1349-7006.1989.tb01729.x","article-title":"Inhibition of tumor cell invasion by Ubenimex (Bestatin) in vitro","volume":"80","author":"Saiki","year":"1989","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1248\/bpb.20.345","article-title":"A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors","volume":"20","author":"Saito","year":"1997","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB35","first-page":"361","article-title":"Inhibitory effect of vasoactive intestinal peptide (VIP) on experimental liver metastasis by murine colon 26-L5 carcinoma cells","volume":"10","author":"Ogasawara","year":"1998","journal-title":"Oncol. Res."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB36","first-page":"82","article-title":"Alpha-melanocyte stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells","volume":"17","author":"Murata","year":"1997","journal-title":"Invasion Metastasis"},{"key":"10.1016\/S0304-3835(01)00737-6_BIB37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1043-2760(05)80006-2","article-title":"Vasoactive intestinal peptide: biologic role in health and disease","volume":"2","author":"Said","year":"1992","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1749-6632.1996.tb17548.x","article-title":"Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP\/PACAP, ATP and carbachol. Role in prostatic proliferation","volume":"805","author":"Guijarro","year":"1996","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/S0304-3835(01)00737-6_BIB39","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1210\/en.141.6.2120","article-title":"Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanism: evidence from in vitro studies on human prostatic and pancreatic cancers","volume":"141","author":"Rekasi","year":"2000","journal-title":"Endocrinology"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383501007376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383501007376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T20:19:24Z","timestamp":1680985164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383501007376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0304383501007376"],"URL":"https:\/\/doi.org\/10.1016\/s0304-3835(01)00737-6","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}